<DOC>
	<DOCNO>NCT00185341</DOCNO>
	<brief_summary>This study design proof-of-concept trial evaluate safety , tolerability , efficacy 1800 mg ( ZK 811752 600 mg give orally three time daily ) 12 week treatment endometriosis associate pelvic pain ( EAPP ) comparison placebo .</brief_summary>
	<brief_title>Study Investigate Efficacy Non-hormonal Drug Against Endometriosis Associated Pelvic Pain</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany . Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Pelvic Pain</mesh_term>
	<criteria>Pain associate proven endometriosis , determine diagnostic measure within 24 month prior start treatment Women cyclic menstrual bleeding Good general health Willingness use barrier contraceptive method condom hormonal contraception Willingness use 3 Ibuprofen 400 tablet pain killer endometriosisrelated pelvic pain Age 18 45 year inclusive Fertile nonfertile Pregnancy , lactation Bearing intrauterine device Current use hormonal agent . Actual history cardiovascular serious disorder</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Endometriosis associate pelvic pain</keyword>
</DOC>